Regulating Between the Notes: The US FDA and the Evolution of the Patient Voice Through Twenty-First Century Regulatory Science
Crossref DOI link: https://doi.org/10.1007/s40271-022-00599-3
Published Online: 2022-09-20
Published Print: 2022-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pitts, Peter J. http://orcid.org/0000-0003-1445-927X
Text and Data Mining valid from 2022-09-20
Version of Record valid from 2022-09-20
Article History
Accepted: 4 September 2022
First Online: 20 September 2022
Declarations
:
: The author reports no conflicts of interest.